Stock Watch: Sanofi’s Seasonal Surge And Novartis’s Material Write-Down
Q3 Earnings Season’s Third Week Brought Contrasting Fortunes
Investors’ different responses to third-quarter sales growth at Sanofi and Novartis left future seasonal sales trends and past business development activity under scrutiny.
